3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Ovarian Neoplasms
29
Uterine Cervical Neoplasms
23
Endometrial Neoplasms
14
Breast Neoplasms
10
Neoplasms
8
Uterine Cervical Dysplasia
5
Carcinoma, Ovarian Epithelial
5
Peritoneal Neoplasms
4
Papillomavirus Infections
4
Lung Neoplasms
4
Fallopian Tube Neoplasms
4
Colorectal Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Pancreatic Neoplasms
3
Neoplastic Cells, Circulating
3
Hereditary Breast and Ovarian Cancer Syndrome
3
Disease
3
Uterine Neoplasms
2
Prostatic Neoplasms
2
Primary Ovarian Insufficiency
2
Ovarian Diseases
2
Melanoma
2
Leukemia
2
Kidney Neoplasms
2
Head and Neck Neoplasms
2
Esophageal Neoplasms
2
Endometrial Hyperplasia
2
Vulvar Neoplasms
1
Urinary Bladder Neoplasms
1
Testicular Neoplasms
1
Interventions
niraparib
3
pembrolizumab
1
Specimen Handling
1
Paclitaxel
1
Nivolumab
1
Magnetic Resonance Spectroscopy
1
Ipilimumab
1
Diphenhydramine
1
Dexamethasone
1
Cimetidine
1
CTLA-4 Antigen
1
Blood Specimen Collection
1
Axitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Cystadenocarcinoma, Serous
×
Blood Specimen Collection
×
Gynecologic
×
Clear all
NCT03150121
2020-02-26
BEDOCA
Sheba Medical Center
Phase NA
Unknown
500 enrolled